Vasoactive Hormones and Oxygen Saturation During Apneic Events in Patients With Obstructive Sleep Apnea
NCT ID: NCT00438412
Last Updated: 2008-04-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
40 participants
OBSERVATIONAL
2006-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We hypothesize that patients with obstructive sleep apnea have an abnormal level of some vasoactive hormones during apneic events during sleep.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vasoactive Hormones During the Night in Patients With Obstructive Sleep Apnea Before and After Treatment With CPAP.
NCT00360659
Vasoactive Hormones During the Night in Patients With Obstructive Sleep Apnea and Healthy Controls.
NCT00291993
Relationship Between Vascular Endothelial Dysfunction and Beat-to-beat Blood Pressure Variability in Patients With OSAS
NCT05548569
Effect of CPAP on Blood Pressure in Patients With Sleep Apnea and Refractory Hypertension
NCT00863135
Sleep Apnea and Refractory Hypertension: Prevalence and Effect of CPAP Treatment
NCT00459914
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Apnea-hypopnea index \< 10
Exclusion Criteria
* Pregnancy
* History or clinical signs of disease in the heart, lungs, brain, liver, kidneys or endocrine organs
* Diabetes
Healthy Controls
* Drug or alcohol abuse
* Pregnancy
* History or clinical signs of disease in the heart, lungs, brain, liver, kidneys or endocrine organs
* Diabetes
20 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Regional Hospital Holstebro
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Medical Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erling B Pedersen, Professor
Role: STUDY_CHAIR
Regional Hospital Holstebro
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Medical Research, Holstebro Hospital
Holstebro, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MED.RES.HOS.2006.01.PHH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.